首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1373380

全球妊娠檢測市場 - 2023-2030

Global Pregnancy Testing Market - 2023-2030

出版日期: 2023年10月18日 | 出版商:

DataM Intelligence | 英文 185 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

懷孕測試尋找一種稱為人類絨毛膜促性腺激素（HCG）的特殊激素，它是在懷孕期間在人體內產生的。妊娠測試透過檢測人類絨毛膜促性腺激素 (HCG) 來發揮作用。在懷孕的最初幾天，血液中的 HCG 水平每 2 至 3 天增加一倍，這表明懷孕正在進展。因此，HCG 的存在高於一定水平表明懷孕。

妊娠測試主要有兩種類型：尿液測試和血液檢查。很少進行血液檢查，因為血液檢查很昂貴，結果往往與尿液檢查相同。驗血不僅可以檢測體內是否有妊娠激素，還可以確定體內荷爾蒙的含量。

市場動態：促進因素與限制因素

妊娠檢測試劑盒的技術進步

技術進步的增加和新產品的推出預計將提高市場成長。自孕測試需求的增加預計將促進市場成長。

例如，2022 年8 月9 日，澳洲新創公司Hoopsy 開發了一種可回收的妊娠測試筆，該測試筆99% 是由紙製成的，旨在阻止每年數以百萬計的拋棄式塑膠版本最終進入垃圾掩埋場。

2023 年 2 月 7 日，高品質、有效的快速檢測產品製造商和分銷商 Abingdon Health plc 與 Salignostics 簽署了新的分銷協議，在英國和愛爾蘭推出首款基於唾液的妊娠檢測產品 Salistick。因此，各種產品推出的增加預計將推動市場成長。

克制

假陽性結果

缺乏認知和不準確的結果正在阻礙市場。大多數測試套件聲稱其準確度為 99%。然而，存在錯誤結果的可能性，因為準確性主要取決於品牌和不當使用等因素。

Pregnancy tests look for a special hormone called human chorionic gonadotropin (HCG) which is developed in a person's body during pregnancy. Pregnancy tests work by detecting human chorionic gonadotropin (HCG). The level of HCG in the blood doubles every 2 to 3 days during the first days of pregnancy, which indicates that the pregnancy is progressing. Thus, the presence of HCG above a certain level indicates pregnancy.

There are two main types of pregnancy tests, urine tests and blood tests. Blood tests are rarely done because they're expensive and tend to have the same result as a urine test. Blood test not only detects whether the pregnancy hormone is in the body, but can also determine how much of the hormone is present.

Market Dynamics: Drivers & Restraints

Technological advancements in pregnancy testing kits

The increase in technological advancements and the introduction of new products is expected to raise the market growth. The increase in the demand for self-pregnancy testing is expected to increase the market growth.

For instance, on August 9, 2022, Australian start-up Hoopsy created a recyclable pregnancy test that is 99 percent made out of paper, aiming to stop millions of single-use plastic versions ending up in landfill each year.

On February 7, 2023, Abingdon Health plc, manufacturer and distributor of high-quality and effective rapid tests, signed a new distribution agreement with Salignostics for the launch of Salistick the first saliva-based pregnancy test in the UK and Ireland. Thus, an increase in a variety of product launches is expected to drive the market growth.

Restraint

False positive results

Lack of awareness, and inaccurate results are hampering the market. Most of the test kits claim that they are 99% accurate. However, there is a possibility of false results, as the accuracy mainly depends on factors like the brand and improper usage.

Segment Analysis

The global pregnancy testing market is segmented based on product type, test type, distribution channel, and region.

Pregnancy test kits segment accounted for 39.5% of the market share

The pregnancy test kit detects the pregnancy hormone, human chorionic gonadotrophin (hCG), in the urine or serum. The test can be taken on the first day of the missing period. Continuous technological advancement in pregnancy test kits is a major factor expected to drive the market's growth. The demand for pregnancy test kits is increasing substantially owing to increasing incidences of unplanned pregnancies globally, driving the global pregnancy testing market.

For instance, on June 10, 2022, Mylab Discovery Solutions launched PregaScreen, an at-home pregnancy test kit that allows women to detect their pregnancy status themselves. With the launch of this test kit, the company marks its foray into the female healthcare segment.

Additionally, on April 14, 2022, Mankind Pharma's pregnancy test kit brand launched a new and advanced pregnancy detection test kit for the Indian market. With this launch, it strived to continually provide advanced testing solutions for confirming the pregnancy. Thus, an increase in the number of product launches is expected to raise the segment growth.

Geographical Analysis

North America is expected to hold a significant position in the global pregnancy testing market share

North American region accounted for the largest market share in 2021. The increased awareness among women leads to the increased demand for self-detecting pregnancy kits, growing fertility disorders, increased unplanned pregnancy rates, increased new product launches, and favorable government initiatives related to family planning.

For instance, according to the latest report in 2023 by the New York Times, the United States has long had one of the highest rates of unintended pregnancy in the world. It is estimated that 46 percent of pregnancies are now unintended.

Additionally, on July 14, 2023, 2San partnered with Proov to distribute their proprietary easy-to-use interpret, at-home fertility tests in select Hy-Vee stores across 8 states in the Midwest. Thus, the above factors are driving the market growth in the region.

COVID-19 Impact Analysis:

The COVID-19 has impacted the ventricular assist devices market positively. During this period there was a rapid increase in the sales of pregnancy kits and fertility kits. The increase in at-home test kit usage has increased the market growth. Thus, there in a rise in the pregnancy testing market growth during this period.

Competitive Landscape

The leading companies with a significant market share include: Abbott Laboratories, BioMerieux SA, EKF Diagnostics Holdings plc, Atlas Medical, Quidel Corporation, BIOSYNEX SA, NG BIOTECH SAS, Axis Medicare, Cardinal Health Inc., and Thermo Fisher Scientific Inc.

Key Developments

In June 2022, PregaScreen, introduced an at-home pregnancy test kit that enables women to determine their pregnancy status, was introduced by Mylab Discovery Solutions.
On March 12, 2021, Lia, has introduced a flushable, biodegradable pregnancy test.

Why Purchase the Report?

To visualize the global pregnancy testing market segmentation based on product type, test type, distribution channel and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of pregnancy testing market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global pregnancy testing market report would provide approximately 62 tables, 59 figures, and 185 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Test Type
3.3. Snippet by Distribution Channel
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological advancements in pregnancy testing kits
  - 4.1.1.2.
- 4.1.2. Restraints
  - 4.1.2.1. False positive results
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Pregnancy Test Kits *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.2.3. Strips/Dipsticks and Cards
- 7.2.4. Digital Devices
- 7.2.5. Midstream Kits
- 7.2.6. Cassettes
7.3. Fertility Test Kits
- 7.3.1. Line indicator kits
- 7.3.2. Digital devices
- 7.3.3. Others

8. By Test Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 8.1.2. Market Attractiveness Index, By Test Type
8.2. HCG Blood *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. HCG Urine
8.4. FSH Urine
8.5. LH Urine

9. By Distribution Channel

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Online Sales *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Gynecology/ Fertility Clinics
9.4. Pharmacies/Drugstores
9.5. Hypermarkets and Supermarkets
9.6. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Abbott Laboratories *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. BioMerieux SA
12.3. EKF Diagnostics Holdings plc
12.4. Atlas Medical
12.5. Quidel Corporation
12.6. BIOSYNEX SA
12.7. NG BIOTECH SAS
12.8. Axis Medicare
12.9. Cardinal Health Inc.
12.10. Thermo Fisher Scientific Inc.